Cita APA

Kudo, M. (2020). Better Efficacy of Ramucirumab in Japanese Patients than in the Global Population with Unresectable Hepatocellular Carcinoma. Liver Cancer.

Chicago Style Citation

Kudo, Masatoshi. "Better Efficacy of Ramucirumab in Japanese Patients Than in the Global Population With Unresectable Hepatocellular Carcinoma." Liver Cancer 2020.

Cita MLA

Kudo, Masatoshi. "Better Efficacy of Ramucirumab in Japanese Patients Than in the Global Population With Unresectable Hepatocellular Carcinoma." Liver Cancer 2020.

Atenció: Aquestes cites poden no estar 100% correctes.